Microneedling: What It Can Treat and Where the Evidence Stops

Medical microneedling can improve the appearance of some acne scars and wrinkles, and certain devices have authorization for other specific scars. It does not erase every scar or reliably address every concern described as uneven skin. The important distinctions are between conventional needling, radiofrequency devices that add heat, superficial home rollers, and treatments that combine needles with additional substances. These are not interchangeable, and clearance of a device does not mean the FDA has approved everything applied with it.

1. What Is Conventional Medical Microneedling?

Conventional microneedling uses small needles to create controlled punctures in living skin. The aim is to trigger a healing response that includes collagen remodeling. Collagen is a structural protein that helps support the skin. This explains the alternative name, collagen induction therapy, but stimulating a healing response does not guarantee a particular cosmetic result.

A clinician may use a motorized pen or another medical needling instrument. Conventional treatment relies on mechanical punctures rather than radiofrequency energy. The assessment, device labeling, infection-control measures and clinician's training all matter because the procedure deliberately injures the skin.

The word controlled should not be read as risk-free. It describes an intended medical process, not a promise that healing, pigmentation or scar formation will be predictable for everyone.

2. What Can Microneedling Treat?

In the United States, the FDA describes authorized uses that include improving facial acne scars, certain facial and neck wrinkles, and surgical scars on the abdomen in adults aged 22 years or older. These are examples across authorized products, not a universal indication for every microneedling device.

An indication is the particular use described in a product's authorization and labeling. It may specify the condition, body area, age group and skin types. A device cleared for facial acne scars should not automatically be presented as cleared for stretch marks, hair loss or scars elsewhere.

2.1 Depressed Acne Scars

Research supports potential improvement in atrophic acne scars, meaning scars that sit below the surrounding skin surface. However, studies differ in their devices, comparisons, outcome measurements and follow-up. Some research also includes RF treatment or additional procedures, so its results cannot simply be transferred to conventional microneedling alone.

A systematic review published in 2021 found encouraging results but identified small trials, differing methods and limited follow-up. It could not pool the results in a meta-analysis because the studies were insufficiently consistent. That supports a discussion about possible improvement, not a universal percentage reduction or a claim that microneedling is the best scar treatment.

Scar shape also matters. Narrow, deep pits and broader depressions are not identical problems. The review found uncertainty about which scar types respond best. An examination is more useful than choosing treatment from the general label acne scars.

2.2 Wrinkles and Other Advertised Uses

Some devices have specific wrinkle indications. For example, one FDA clearance distinguishes between neck-wrinkle treatment for a restricted range of skin types and facial acne-scar treatment across all Fitzpatrick skin types. Fitzpatrick categories describe skin's response to sunlight. This illustrates why the exact device and indication matter more than a broad statement that microneedling is FDA-cleared.

Dermatology patient information also discusses uses such as stretch marks, dark spots and uneven texture. A list of uses in clinical practice is not the same as a list of FDA-cleared indications. If your concern falls outside the proposed device's labeling, ask what evidence supports that particular use and what remains uncertain.

3. What Results Should You Not Expect?

The appropriate goal is improvement in appearance, not scar removal or flawless skin. Results develop gradually, and more than one procedure may be needed. The FDA cautions that the desired outcome may not occur, improvement may be temporary, and maintaining it may involve additional procedures.

Before agreeing to treatment, ask the clinician to describe the intended change in ordinary language. Does improvement mean a less noticeable depression, softer-looking lines or a change in texture? These are more useful goals than an undefined promise of rejuvenation.

Also ask how the result will be assessed and when it will be reviewed. Photographs can support a discussion, but a photograph showing several treatments together cannot establish what conventional microneedling achieved by itself.

No single treatment has to address every concern. Depending on the diagnosis, alternatives may include laser resurfacing, chemical peels, fillers or scar-directed procedures. Each needs its own risk-benefit assessment. The evidence does not justify assuming that microneedling is universally better, safer or more effective than those options. Choosing no cosmetic procedure is also a reasonable option.

4. Why Skin History and Skin Tone Need Individual Assessment

A consultation should include an examination and a discussion of your medical history, previous skin reactions and treatment goals. Individual clinical advice is necessary because general descriptions cannot establish whether your skin or health history fits a particular device's requirements.

4.1 Pigment Changes and Scarring

The American Academy of Dermatology's patient guide, last updated July 17, 2023, describes microneedling broadly as suitable across skin tones. The FDA's guidance adds an important qualification: darkening or lightening can occur, and some authorized devices were not studied in people with darker skin types. These statements should not be compressed into a guarantee of safety for everyone.

Darker skin is not a blanket exclusion from all conventional microneedling. Equally, evidence involving one device, indication and population does not establish suitability for another. Ask whether the proposed treatment was studied in people with a similar skin tone and whether your history of discoloration changes the assessment.

Tell the clinician about previous long-lasting dark marks, loss of pigment, poor healing or keloids. Keloids are raised scars that grow beyond the original injury. A treatment intended to improve depressed scars should not be assumed appropriate for someone prone to abnormal raised scarring.

4.2 Conditions, Medicines and Allergies

Device warnings and precautions can differ. One prescription system's patient labeling excludes treatment in circumstances including open or irritated skin, certain bleeding disorders, pregnancy or nursing, and current isotretinoin use. It also identifies populations in which the device has not been evaluated. These product-specific details are another reason to request the actual patient information rather than rely on general marketing.

Topics to raise during consultation include:

• Active acne, rashes, wounds, infection or recurrent cold sores.
• Eczema, psoriasis or other conditions affecting the intended treatment area.
• Diabetes, immune suppression or a history of delayed healing.
• Bleeding problems and medicines that affect bleeding.
• Current or recent isotretinoin use and previous cosmetic procedures.
• Allergies to needle materials, numbing medicines or products used during treatment.

Bring a medication and skin-care list. Do not change prescribed medicines based on a general article or a booking checklist without advice from the responsible clinician.

5. Adverse Effects and Infection Control

Common effects described by the FDA include redness, discomfort, dryness, tightness, itching, peeling, bruising, bleeding and crusting. These often resolve, but recovery is not a fixed deadline. Less common problems include infection, cold-sore reactivation and darker or lighter pigmentation. Scarring and persistent discoloration are also relevant concerns.

Ask how the team distinguishes an expected reaction from a complication, who handles concerns after the appointment and where you should obtain urgent assessment. The FDA advises immediate medical attention for signs or symptoms of complications. Do not assume a worsening or concerning reaction is normal simply because temporary irritation was discussed beforehand.

5.1 A New Cartridge Is Required for Every Session

The FDA advises using a new needle cartridge for each patient and each treatment session, including repeat treatment of the same person. Cleaning a used cartridge does not make reuse acceptable. Reusable equipment must be cleaned and disinfected according to its instructions.

Useful questions include whether the cartridge is sterile and single-use, how reusable components are processed, and how the team follows the manufacturer's infection-control instructions. A description such as medical grade is not an adequate substitute for those answers.

Request written aftercare that addresses the products you normally use and your sun exposure. Skin can be more sensitive after treatment. Instructions about resuming products should come from the treating team rather than a universal online routine.

6. Device Clearance Does Not Approve Every Add-On

The FDA states that microneedling devices are not approved to deliver cosmetics, topical medicines, vitamin solutions, drugs or blood products such as platelet-rich plasma, known as PRP, into the skin. It also states that it has not cleared microneedling devices for use with another product and has not reviewed the safety or effectiveness of those combinations.

Keep three questions separate: whether the device is authorized, whether the additional substance has an appropriate regulatory status, and whether evidence supports using them together in the proposed way. An affirmative answer to the first does not settle the others.

There is also a distinction between an accessory specified in a device's instructions and an independently selected treatment add-on. FDA review documentation for one system describes a hydrogel wound dressing used to reduce abrasion and friction while explicitly excluding delivery of cosmetics, drugs or biologics beneath the skin. That does not create permission to substitute any serum or biological preparation.

Do not treat PRP or exosome branding as evidence of extra benefit. Ask for the exact substance, intended purpose, regulatory status and evidence for the proposed combination. Evidence or clearance for conventional needling alone is not sufficient justification.

7. Keep RF Devices and Home Rollers Separate

RF microneedling adds tissue heating and requires a separate safety discussion. On October 15, 2025, the FDA issued a communication about reports of serious complications with certain RF uses, including burns, scarring, fat loss, disfigurement and nerve damage. Those reports do not establish a complication rate, nor should they be used to assign the same risk profile to conventional needling. They do show why the treatment category must be clear before consent.

Home rollers are a different issue. The FDA has not authorized microneedling medical devices for over-the-counter sale. Some superficial products are not regulated as medical devices because their intended claims and effects are limited to the skin surface. That is not evidence that they reproduce medical treatment. The AAD warns that home products can cause injury, infection, scarring or changes in skin color, including when they unexpectedly penetrate the skin.

8. Questions to Take to a Consultation

A useful consultation should leave you understanding the proposed procedure, not just its name. Consider asking:

• What specific condition are you treating, and what improvement is realistic?
• Is this conventional microneedling or a device that delivers RF energy?
• What is the exact device, and does its labeling cover my concern, body area and skin type?
• What training and experience do you have with this device and people with similar skin histories?
• Does my history suggest a reason to postpone treatment or consider another option?
• Will any substance be added, and what supports that combination?
• How are single-use cartridges and reusable components handled?
• What follow-up, complication assessment and written aftercare are provided?

The central decision is not whether microneedling works in the abstract. It is whether a particular conventional device, used for a defined concern after an appropriate assessment, offers a worthwhile potential improvement for you. Clear limits and specific answers are more informative than promises of collagen stimulation alone.